175 related articles for article (PubMed ID: 2097599)
21. [Local anesthetics and their quaternary derivatives as anti-arrhythmia agents].
Gendenshteĭn EI; Tsybusov AP
Farmakol Toksikol; 1985; 48(1):112-7. PubMed ID: 2579846
[No Abstract] [Full Text] [Related]
22. [The effect of anti-arrhythmia agents on ventricular arrhythmias arising as a consequence of disorders in the myocardial blood supply].
Gendenshteĭn EI; Kostin IaV; Markelova NN; Balashov VP; Oleĭnikov VE; Perevarin AV
Farmakol Toksikol; 1990; 53(4):28-30. PubMed ID: 2226754
[TBL] [Abstract][Full Text] [Related]
23. Potential antiarrhythmic agents. I. Antiarrhythmic activity of basic N-(alpha, alpha-dimethylbenzyl)acylamines.
Akerman B; Lindberg UH
Acta Pharm Suec; 1984; 21(2):103-8. PubMed ID: 6475539
[No Abstract] [Full Text] [Related]
24. [Anti-arrhythmic activity of a new selenium-derivative preparation].
Ventslavskaia TA; Stazhadze LL; Korzhova VV
Farmakol Toksikol; 1984; 47(2):38-41. PubMed ID: 6714399
[TBL] [Abstract][Full Text] [Related]
25. [Some aspects of the antiarrhythmic effect of glialin].
Khisatmutdinova RIu; Baschenko NZh; Zarudiĭ FS; Gabdrakhmanova SF; Makara NS; Sapozhnikova TA
Eksp Klin Farmakol; 2006; 69(3):26-8. PubMed ID: 16878494
[TBL] [Abstract][Full Text] [Related]
26. [Effect of lorcainide on experimental arrhythmias in comparison with other antiarrhythmic agents].
Ma X; Li ZW
Yao Xue Xue Bao; 1986 Apr; 21(4):241-5. PubMed ID: 3788590
[No Abstract] [Full Text] [Related]
27. [Pharmacological study of quaternary trimecaine derivatives].
Gendenshteĭn EI; Tsybusov AP; Zhukauskaĭte LN; Stankevichius AP; Bukauskas FF
Farmakol Toksikol; 1983; 46(4):36-40. PubMed ID: 6617835
[TBL] [Abstract][Full Text] [Related]
28. [Experimental arrhythmia models. Critical study of correlations with arrhythmias observed in clinical practice].
Dupuis BA; Vincent AC
Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():17-27. PubMed ID: 6803699
[TBL] [Abstract][Full Text] [Related]
29. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
Maĭmeskulova LA; Maslov LN
Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
[TBL] [Abstract][Full Text] [Related]
30. [Amides of 7-theophyllineacetic acid with antiarrhythmic action].
Eckstein M; Cegła M
Acta Pol Pharm; 1987; 44(1):12-5. PubMed ID: 3673625
[No Abstract] [Full Text] [Related]
31. [The relationship between the chemical structure and anti-arrhythmia action of a number of omega-aminoacyl-3-carbalcoxyaminodibenzazepines].
Gritsenko AN; Lyskovtsev VV; Senova ZP; Skoldinov AP; Stark A; Wunderlich G; Poppe H; Barch R
Farmakol Toksikol; 1990; 53(3):30-2. PubMed ID: 2387375
[TBL] [Abstract][Full Text] [Related]
32. [Search for and study of antiarrhythmic substances among crown ethers].
Luk'ianenko NG; Bogatskiĭ AV; Iaroshenko IM; Vongaĭ VG; Nazarov EI
Farmakol Toksikol; 1984; 47(5):29-32. PubMed ID: 6238839
[TBL] [Abstract][Full Text] [Related]
33. Potential antiarrhythmic agents. II. Antiarrhythmic activity of basic N-(substituted phenyl and benzyl)dipeptides.
Lindberg UH; Akerman B
Acta Pharm Suec; 1985; 22(6):321-34. PubMed ID: 3832783
[No Abstract] [Full Text] [Related]
34. [5-Aminoacetamido-4,6-dimethyl-2-hydroxy-isophthalic acid diethyl ester: synthesis and investigation of antiarrhythmic properties. 92. Studies of pyran derivatives].
Eiden F; Leister HP; Mayer D
Arzneimittelforschung; 1983; 33(1):101-5. PubMed ID: 6681960
[No Abstract] [Full Text] [Related]
35. [Comparative characteristics of the activity of lithium preparations and anti-arrhythmia agents in strophanthin, calcium chloride and barium chloride arrhythmias in an experiment].
Galenko-Iaroshevskiĭ PA; Tikhonov AV
Farmakol Toksikol; 1985; 48(2):64-8. PubMed ID: 3996574
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
37. [Synthesis and biological properties of various amino alcohol derivatives of xanthone].
Marona H; Krupińska J; Cebo B; Chłoń G
Acta Pol Pharm; 1989; 46(3):227-31. PubMed ID: 2618768
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the heart (22). Inhibitory effect of an atrial peptide (AAP) on drug-induced arrhythmia].
Aonuma S; Kohama Y; Makino T; Hattori K
Yakugaku Zasshi; 1983 Jun; 103(6):662-6. PubMed ID: 6689179
[No Abstract] [Full Text] [Related]
39. [Comparative effectiveness of the beta-(N,N-diethylamino)ethylamide hydrochloride of fusaric acid, obzidan and atenolol in experimental adrenaline-induced cardiac arrhythmia].
Savina MD
Farmakol Toksikol; 1986; 49(3):47-50. PubMed ID: 3720934
[TBL] [Abstract][Full Text] [Related]
40. Antiarrhythmic profile and endothelial action of novel decahydroquinoline derivatives.
Kozlovski VI; Vdovichenko VP; Chlopicki S; Malchik SS; Praliyev KD; Zcilkibayev OT
Pol J Pharmacol; 2004; 56(6):767-74. PubMed ID: 15662089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
